Alex Haahr Gouliaev
Amministratore Delegato presso Atz Holding ApS
Profilo
Alex Haahr Gouliaev was the founder of Nuevolution AB, founded in 2001, where he held the title of Chief Executive Officer.
Currently, he is the Chief Executive Officer at Nuevolution A since 2004 and also holds the same title at Atz Holding ApS.
His former job was at NTG Nordic Transport Group A, where he held the position of Director & Director-Chemistry Department from 1996 to 2001.
Dr. Gouliaev received his doctorate degree from the University of Aarhus in 1996 and his graduate degree from the University of Southern Denmark in 1994.
Posizioni attive di Alex Haahr Gouliaev
| Società | Posizione | Inizio |
|---|---|---|
| Atz Holding ApS | Amministratore Delegato | - |
Nuevolution A/S
 Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Amministratore Delegato | 30/09/2004 |
Precedenti posizioni note di Alex Haahr Gouliaev
| Società | Posizione | Fine |
|---|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Direttore/Membro del Consiglio | 01/01/2001 |
| NUEVOLUTION AB (PUBL) | Amministratore Delegato | - |
Formazione di Alex Haahr Gouliaev
| University of Aarhus | Doctorate Degree |
| University of Southern Denmark | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| Aziende private | 3 |
|---|---|
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Atz Holding ApS | |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Nuevolution A/S engages in research and experimental development on biotechnology. It produces and commercializes technologies for the manufacture of substances for use in the pharmaceutical industry by screening non-biological polymers and low-molecular substances. The company was founded on May 8, 2001 and is headquartered in Copenhagen, Denmark. | Commercial Services |
- Borsa valori
- Insiders
- Alex Haahr Gouliaev
